IBDEI0VY ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15525,2)
 ;;=Dysmenorrhea^37592
 ;;^UTILITY(U,$J,358.3,15526,0)
 ;;=625.0^^81^945^19
 ;;^UTILITY(U,$J,358.3,15526,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15526,1,4,0)
 ;;=4^625.0
 ;;^UTILITY(U,$J,358.3,15526,1,5,0)
 ;;=5^Dyspareunia
 ;;^UTILITY(U,$J,358.3,15526,2)
 ;;=Dyspareunia^37604
 ;;^UTILITY(U,$J,358.3,15527,0)
 ;;=788.1^^81^945^20
 ;;^UTILITY(U,$J,358.3,15527,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15527,1,4,0)
 ;;=4^788.1
 ;;^UTILITY(U,$J,358.3,15527,1,5,0)
 ;;=5^Dysuria
 ;;^UTILITY(U,$J,358.3,15527,2)
 ;;=Dysuria^37716
 ;;^UTILITY(U,$J,358.3,15528,0)
 ;;=621.0^^81^945^21
 ;;^UTILITY(U,$J,358.3,15528,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15528,1,4,0)
 ;;=4^621.0
 ;;^UTILITY(U,$J,358.3,15528,1,5,0)
 ;;=5^Endometrial Polyps
 ;;^UTILITY(U,$J,358.3,15528,2)
 ;;=^270517
 ;;^UTILITY(U,$J,358.3,15529,0)
 ;;=617.9^^81^945^22
 ;;^UTILITY(U,$J,358.3,15529,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15529,1,4,0)
 ;;=4^617.9
 ;;^UTILITY(U,$J,358.3,15529,1,5,0)
 ;;=5^Endometriosis, site unsp
 ;;^UTILITY(U,$J,358.3,15529,2)
 ;;=^40463
 ;;^UTILITY(U,$J,358.3,15530,0)
 ;;=054.71^^81^945^24
 ;;^UTILITY(U,$J,358.3,15530,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15530,1,4,0)
 ;;=4^054.71
 ;;^UTILITY(U,$J,358.3,15530,1,5,0)
 ;;=5^Herpes simplex of vulva
 ;;^UTILITY(U,$J,358.3,15530,2)
 ;;=^266574
 ;;^UTILITY(U,$J,358.3,15531,0)
 ;;=704.1^^81^945^25
 ;;^UTILITY(U,$J,358.3,15531,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15531,1,4,0)
 ;;=4^704.1
 ;;^UTILITY(U,$J,358.3,15531,1,5,0)
 ;;=5^Hirsutism
 ;;^UTILITY(U,$J,358.3,15531,2)
 ;;=Hirsutism^57407
 ;;^UTILITY(U,$J,358.3,15532,0)
 ;;=V07.4^^81^945^26
 ;;^UTILITY(U,$J,358.3,15532,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15532,1,4,0)
 ;;=4^V07.4
 ;;^UTILITY(U,$J,358.3,15532,1,5,0)
 ;;=5^Hormone replacement therapy
 ;;^UTILITY(U,$J,358.3,15532,2)
 ;;=^295199
 ;;^UTILITY(U,$J,358.3,15533,0)
 ;;=625.6^^81^945^28
 ;;^UTILITY(U,$J,358.3,15533,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15533,1,4,0)
 ;;=4^625.6
 ;;^UTILITY(U,$J,358.3,15533,1,5,0)
 ;;=5^Incontinence, stress
 ;;^UTILITY(U,$J,358.3,15533,2)
 ;;=^114717
 ;;^UTILITY(U,$J,358.3,15534,0)
 ;;=628.9^^81^945^29
 ;;^UTILITY(U,$J,358.3,15534,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15534,1,4,0)
 ;;=4^628.9
 ;;^UTILITY(U,$J,358.3,15534,1,5,0)
 ;;=5^Infertility
 ;;^UTILITY(U,$J,358.3,15534,2)
 ;;=Infertility^62820
 ;;^UTILITY(U,$J,358.3,15535,0)
 ;;=626.4^^81^945^30
 ;;^UTILITY(U,$J,358.3,15535,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15535,1,4,0)
 ;;=4^626.4
 ;;^UTILITY(U,$J,358.3,15535,1,5,0)
 ;;=5^Irregular menstruation
 ;;^UTILITY(U,$J,358.3,15535,2)
 ;;=^270567
 ;;^UTILITY(U,$J,358.3,15536,0)
 ;;=626.2^^81^945^31
 ;;^UTILITY(U,$J,358.3,15536,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15536,1,4,0)
 ;;=4^626.2
 ;;^UTILITY(U,$J,358.3,15536,1,5,0)
 ;;=5^Menometrorrhagia
 ;;^UTILITY(U,$J,358.3,15536,2)
 ;;=Menometrorrhagia^75895
 ;;^UTILITY(U,$J,358.3,15537,0)
 ;;=627.2^^81^945^43
 ;;^UTILITY(U,$J,358.3,15537,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15537,1,4,0)
 ;;=4^627.2
 ;;^UTILITY(U,$J,358.3,15537,1,5,0)
 ;;=5^Perimenopause
 ;;^UTILITY(U,$J,358.3,15537,2)
 ;;=Perimenopause^75863
 ;;^UTILITY(U,$J,358.3,15538,0)
 ;;=611.79^^81^945^33
 ;;^UTILITY(U,$J,358.3,15538,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,15538,1,4,0)
 ;;=4^611.79
 ;;^UTILITY(U,$J,358.3,15538,1,5,0)
 ;;=5^Nipple Discharge
 ;;^UTILITY(U,$J,358.3,15538,2)
 ;;=Nipple Discharge^270462
 ;;^UTILITY(U,$J,358.3,15539,0)
 ;;=278.00^^81^945^34
 ;;^UTILITY(U,$J,358.3,15539,1,0)
 ;;=^358.31IA^5^2
 ;;
 ;;$END ROU IBDEI0VY
